Sortiert nach PI

Publikationen - sortiert nach Principle Investigator

• Bsteh G, Macher S, Krajnc N, Pruckner P, Marik W, Mitsch C, Novak K, Pemp B, Wöber C (2023) Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes Headache,
• Krajnc N, Dal-Bianco A, Leutmezer F, Kasprian G, Pemp B, Kornek B, Berger T, Rommer P, Hametner S, Lassmann H, Bsteh G (2023) Association of paramagnetic rim lesions and retinal layer thickness in patients with multiple sclerosis Mult Scler, 29(3): 374-384

• Hametner S, Silvaieh S, Thurnher M, Dal-Bianco A, Cetin H, Ponleitner M, Zebenholzer K, Pemp B, Trattnig S, Rössler K, Berger T, Lassmann H, Hainfellner J, Bsteh G (2022) A case of primary optic pathway demyelination caused by oncocytic oligodendrogliopathy of unknown origin Acta Neuropathologica Communications, 10 (1): 160
• Krajnc N, Bsteh G, Kasprian G, Zrzavy T, Kornek B, Berger T, Leutmezer F, Rommer P, Lassmann H, Hametner S, Dal-Bianco A (2022) Peripheral Hemolysis in Relation to Iron Rim Presence and Brain Volume in Multiple Sclerosis Front Neurol, 13: 928582

• Altmann P, Leithner K, Leutmezer F, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Sexuality and Multiple Sclerosis: Patient and Doctor Perspectives JSM, 18 (4): 743-749
• Altmann P, Leutmezer F, Leithner K, Monschein T, Ponleitner M, Stattmann M, Rommer P, Zrzavy T, Zulehner G, Berek K, Berger T, Bsteh G (2021) Predisposing Factors for Sexual Dysfunction in Multiple Sclerosis Front Neurol, 12: 618370
• Monschein T, Schestak C, Schillerwein-Kral C, Leutmezer F, Berger T, Bsteh G, Seidel S (2021) Restless Legs Syndrome in Multiple Sclerosis: Risk factors and effect on sleep quality – a case-control study Mult Scler Relat Disord., 51: 102916
• Bsteh G, Hegen H, Altmann P, Auer M, Berek K, Di Pauli F, Leutmezer F, Rommer P, Wurth S, Zinganell A, Zrzavy T, Deisenhammer F, Berger T (2021) Retinal layer thinning predicts treatment failure in relapsing multiple sclerosis Eur J Neurol, 28 (6): 2037-2045
• Zrzavy T, Daniels E, Stuka N, Weber D, Winkelmann A, Rauschka H, Hecker M, Aboulenein-Djamshidian F, Meister S, Leutmezer F, Berger T, Bsteh G, Zettl UK, Rommer P (2021) Rituximab versus mitoxantrone: comparing effectiveness and safety in advanced relapsing multiple sclerosis Therapeutic Advances in Chronic Disease, 12: 204062232110243

• Zamarian L, Berger T, Pertl M, Bsteh G, Djamshidian A, Deisenhammer F, Delazer M (2020) Decision making and framing effects in multiple sclerosis Eur J Neurol, 28 (4): 1292-1298
• Monschein T, Salhofer-Polanyi S, Altmann P, Zrzavy T, Dal-Bianco A, Bsteh G, Rommer P, Berger T, Leutmezer F (2020) Should I stop or should I go on? Disease modifying therapy after the first clinical episode of multiple sclerosis J Neurol, 268 (4): 1247-1253

• Walleczek NK, Rauschka H, Bsteh G, Birkl CB, Khalil M, Fuchs S, Enzinger C, Fazekas F, Eggers C, Leutmezer F, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Koppi S, Sellner J, Kraus J, Assar H, Gugger M, Ehling R, Moser H, Raber B, Liendl H, Parigger S, Mayr M, Hiller MS, Meister B, Morgenstern G, Spiess HK, Kempf I, Cisar A, Bachler H, Lehninger R, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F (2015) Month-of-birth-effect in multiple sclerosis in Austria Mult Scler, 21: 102-103